Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

221.

Seymour S. Kety 1915-2000

Nat. Med.
Holzman PS.
| 7 11, 2000
222.

Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies.

Nat. Med.
Trojan A, Schultze JL, Witzens M, Vonderheide RH, Ladetto M, Donovan JW, Gribben JG.
| 6 3, 2000
223.

Active movement of T cells away from a chemokine.

Nat. Med.
Poznansky MC, Olszak IT, Foxall R, Evans RH, Luster AD, Scadden DT.
| 5 10, 2000
225.

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.

Nat. Med.
Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, Shaffer J, Sayegh MH, Sykes M.
| 3 31, 2000
226.

HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine.

Nat. Med.
Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK.
| 3 31, 2000
227.

In vivo magnetic resonance imaging of transgene expression.

Nat. Med.
Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP.
| 3 4, 2000
228.

p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes.

Nat. Med.
Boussiotis VA, Freeman GJ, Taylor PA, Berezovskaya A, Grass I, Blazar BR, Nadler LM.
| 3 4, 2000
229.

Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population.

Nat. Med.
Anderson DE, Bieganowska KD, Bar-Or A, Oliveira EM, Carreno B, Collins M, Hafler DA.
| 2 2, 2000
230.

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.

Nat. Med.
Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Lu Y, Wright JE, Chou TC, Ruprecht RM.
| 2 2, 2000
233.

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

Nat. Med.
Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB.
| 2 2, 2000
234.

PR39, a peptide regulator of angiogenesis.

Nat. Med.
Li J, Post M, Volk R, Gao Y, Li M, Metais C, Sato K, Tsai J, Aird W, Rosenberg RD, Hampton TG, Sellke F, Carmeliet P, Simons M.
| 12 29, 1999
235.

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.

Nat. Med.
Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR.
| 12 2, 1999
237.

Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1.

Nat. Med.
Gohongi T, Fukumura D, Boucher Y, Yun CO, Soff GA, Compton C, Todoroki T, Jain RK.
| 9 30, 1999
238.

Mental illness and the sciences of brain and behavior.

Nat. Med.
Kety SS.
| 9 30, 1999
239.

Upregulation of RGS7 may contribute to tumor necrosis factor-induced changes in central nervous function.

Nat. Med.
Benzing T, Brandes R, Sellin L, Schermer B, Lecker S, Walz G, Kim E.
| 7 30, 1999
240.

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses.

Nat. Med.
Ikeda K, Ichikawa T, Wakimoto H, Silver JS, Deisboeck TS, Finkelstein D, Harsh GR, Louis DN, Bartus RT, Hochberg FH, Chiocca EA.
| 7 30, 1999